ORIX - SPONSORED ADR (IX) Fundamental Analysis & Valuation

NYSE:IX • US6863301015

Current stock price

31.77 USD
+0.73 (+2.35%)
Last:

This IX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. IX Profitability Analysis

1.1 Basic Checks

  • IX had positive earnings in the past year.
  • IX had a positive operating cash flow in the past year.
  • IX had positive earnings in each of the past 5 years.
  • Each year in the past 5 years IX had a positive operating cash flow.
IX Yearly Net Income VS EBIT VS OCF VS FCFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T

1.2 Ratios

  • IX has a Return On Assets of 2.50%. This is in the better half of the industry: IX outperforms 64.65% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.90%, IX is in line with its industry, outperforming 55.56% of the companies in the same industry.
  • The Return On Invested Capital of IX (3.15%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for IX is significantly below the industry average of 8.00%.
  • The 3 year average ROIC (2.63%) for IX is below the current ROIC(3.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROIC 3.15%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
IX Yearly ROA, ROE, ROICIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • IX has a better Profit Margin (14.49%) than 61.62% of its industry peers.
  • In the last couple of years the Profit Margin of IX has declined.
  • With a decent Operating Margin value of 19.97%, IX is doing good in the industry, outperforming 69.70% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IX has remained more or less at the same level.
  • With a decent Gross Margin value of 42.41%, IX is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • IX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
IX Yearly Profit, Operating, Gross MarginsIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. IX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IX is destroying value.
  • The number of shares outstanding for IX has been reduced compared to 1 year ago.
  • The number of shares outstanding for IX has been reduced compared to 5 years ago.
  • The debt/assets ratio for IX has been reduced compared to a year ago.
IX Yearly Shares OutstandingIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IX Yearly Total Debt VS Total AssetsIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T

2.2 Solvency

  • Based on the Altman-Z score of 0.67, we must say that IX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.67, IX perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • The Debt to FCF ratio of IX is 3051.64, which is on the high side as it means it would take IX, 3051.64 years of fcf income to pay off all of its debts.
  • IX has a worse Debt to FCF ratio (3051.64) than 61.62% of its industry peers.
  • A Debt/Equity ratio of 1.47 is on the high side and indicates that IX has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.47, IX is not doing good in the industry: 62.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Altman-Z 0.67
ROIC/WACC0.85
WACC3.69%
IX Yearly LT Debt VS Equity VS FCFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

2.3 Liquidity

  • IX has a Current Ratio of 0.48. This is a bad value and indicates that IX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IX has a Current ratio (0.48) which is in line with its industry peers.
  • A Quick Ratio of 0.43 indicates that IX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.43, IX is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.43
IX Yearly Current Assets VS Current LiabilitesIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500B 1T 1.5T 2T 2.5T

3

3. IX Growth Analysis

3.1 Past

  • IX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.80%.
  • The Earnings Per Share has been decreasing by -1.09% on average over the past years.
  • IX shows a small growth in Revenue. In the last year, the Revenue has grown by 6.76%.
  • The Revenue has been decreasing by -1.43% on average over the past years.
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.51% on average over the next years. This is quite good.
  • IX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.00% yearly.
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y21.15%
EPS Next 5Y15.51%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y8.11%
Revenue Next 5Y7%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IX Yearly Revenue VS EstimatesIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1T 2T 3T
IX Yearly EPS VS EstimatesIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100 200 300 400

5

4. IX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 21.61 indicates a rather expensive valuation of IX.
  • The rest of the industry has a similar Price/Earnings ratio as IX.
  • The average S&P500 Price/Earnings ratio is at 27.18. IX is valued slightly cheaper when compared to this.
  • IX is valuated correctly with a Price/Forward Earnings ratio of 14.60.
  • The rest of the industry has a similar Price/Forward Earnings ratio as IX.
  • The average S&P500 Price/Forward Earnings ratio is at 37.96. IX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 21.61
Fwd PE 14.6
IX Price Earnings VS Forward Price EarningsIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IX is valued a bit cheaper than 68.69% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IX is valued a bit more expensive than 61.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2609.62
EV/EBITDA 9.91
IX Per share dataIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • IX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as IX's earnings are expected to grow with 21.15% in the coming years.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y21.71%
EPS Next 3Y21.15%

7

5. IX Dividend Analysis

5.1 Amount

  • IX has a Yearly Dividend Yield of 3.15%.
  • IX's Dividend Yield is a higher than the industry average which is at 1.86.
  • Compared to an average S&P500 Dividend Yield of 1.82, IX pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.15%

5.2 History

  • The dividend of IX is nicely growing with an annual growth rate of 7.63%!
  • IX has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of IX decreased in the last 3 years.
Dividend Growth(5Y)7.63%
Div Incr Years2
Div Non Decr Years2
IX Yearly Dividends per shareIX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

5.3 Sustainability

  • IX pays out 31.18% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of IX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.18%
EPS Next 2Y21.71%
EPS Next 3Y21.15%
IX Yearly Income VS Free CF VS DividendIX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B -200B -400B
IX Dividend Payout.IX Dividend Payout, showing the Payout Ratio.IX Dividend Payout.PayoutRetained Earnings

IX Fundamentals: All Metrics, Ratios and Statistics

ORIX - SPONSORED ADR

NYSE:IX (4/14/2026, 2:46:23 PM)

31.77

+0.73 (+2.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-11
Inst Owners50.72%
Inst Owner Change-0.22%
Ins Owners0%
Ins Owner Change0%
Market Cap34.89B
Revenue(TTM)3.13T
Net Income(TTM)439.75B
Analysts77.5
Price Target35.46 (11.61%)
Short Float %0.06%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield 3.15%
Yearly Dividend0.75
Dividend Growth(5Y)7.63%
DP31.18%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.73%
PT rev (3m)19%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.22%
EPS NY rev (3m)3.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.8%
Revenue NY rev (3m)2.64%
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE 14.6
P/S 1.84
P/FCF 2609.62
P/OCF 4.26
P/B 1.26
P/tB 1.8
EV/EBITDA 9.91
EPS(TTM)1.47
EY4.63%
EPS(NY)2.18
Fwd EY6.85%
FCF(TTM)0.01
FCFY0.04%
OCF(TTM)7.45
OCFY23.46%
SpS17.29
BVpS25.3
TBVpS17.7
PEG (NY)0.84
PEG (5Y)N/A
Graham Number28.93
Profitability
Industry RankSector Rank
ROA 2.5%
ROE 9.9%
ROCE 4.53%
ROIC 3.15%
ROICexc 3.5%
ROICexgc 4.93%
OM 19.97%
PM (TTM) 14.49%
GM 42.41%
FCFM 0.07%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.63%
ROIC(5y)2.49%
ROICexc(3y)2.88%
ROICexc(5y)2.73%
ROICexgc(3y)3.79%
ROICexgc(5y)3.66%
ROCE(3y)3.76%
ROCE(5y)3.56%
ROICexgc growth 3Y0.25%
ROICexgc growth 5Y0.16%
ROICexc growth 3Y1.76%
ROICexc growth 5Y0.31%
OM growth 3Y3.26%
OM growth 5Y1.35%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 3051.64
Debt/EBITDA 6.49
Cap/Depr 327.15%
Cap/Sales 43.02%
Interest Coverage 250
Cash Conversion 130.12%
Profit Quality 0.49%
Current Ratio 0.48
Quick Ratio 0.43
Altman-Z 0.67
F-Score7
WACC3.69%
ROIC/WACC0.85
Cap/Depr(3y)325.04%
Cap/Depr(5y)298.28%
Cap/Sales(3y)43.48%
Cap/Sales(5y)39.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%36.63%
EPS Next Y25.58%
EPS Next 2Y21.71%
EPS Next 3Y21.15%
EPS Next 5Y15.51%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%12.46%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y8.11%
Revenue Next 5Y7%
EBIT growth 1Y1.57%
EBIT growth 3Y7.89%
EBIT growth 5Y6.16%
EBIT Next Year13025.2%
EBIT Next 3Y456.28%
EBIT Next 5YN/A
FCF growth 1Y111.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.39%
OCF growth 3Y5.62%
OCF growth 5Y4.52%

ORIX - SPONSORED ADR / IX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ORIX - SPONSORED ADR (IX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IX.


Can you provide the valuation status for ORIX - SPONSORED ADR?

ChartMill assigns a valuation rating of 5 / 10 to ORIX - SPONSORED ADR (IX). This can be considered as Fairly Valued.


How profitable is ORIX - SPONSORED ADR (IX) stock?

ORIX - SPONSORED ADR (IX) has a profitability rating of 6 / 10.


How financially healthy is ORIX - SPONSORED ADR?

The financial health rating of ORIX - SPONSORED ADR (IX) is 2 / 10.


Is the dividend of ORIX - SPONSORED ADR sustainable?

The dividend rating of ORIX - SPONSORED ADR (IX) is 7 / 10 and the dividend payout ratio is 31.18%.